Phase I/IIa Clinical Trials Overview
ProMedica Clinical Research Center stands at the forefront of clinical research because of our commitment to bring scientific integrity and reliability to the healthcare industry. Our clinical research team has been working with leading pharmaceutical, biotechnology, and medical device companies for nearly 40 years.
ProMedica CRC continues its commitment to the advancement of clinical research in Boston. Our professional team understands the intricacies of Phase I-IIa Clinical Trials and is dedicated to the precise and efficient management of your study. The safety of our volunteers and committed service to our clients are the hallmarks of ProMedica CRC.
Phase I-IIa Trials Capabilities & Services
Throughout ProMedica CRC's nearly 40 years of experience, we have worked with most aspects of Phase I-IIa Clinical Trials. Some of our capabilities and services include First Time In Man studies, Fed/Fasted studies, and Drug/Drug interaction studies. ProMedica CRC offers full time physician on site, a full time physician on call 24 hours a day, as well as two physicians present on dosing days. We offer our clients online accessibility to real-time lab results, as well as private monitoring accommodations. ProMedica CRC uses the services of several Institutional Review Boards who meet on a frequent basis to expedite the approval of studies.
Our extensive database draws from the diverse population of the greater Boston area. Such diversity allows us access to subjects in most therapeutic areas, and ensures successful recruitment.
All subjects know that their safety is our priority, resulting in our retention rate of over 99%.